# Release notes

## 22.11

### Release date

24 November 2022

### Highlights

In addition to continuous updates from our data providers, we have introduced the following new features:&#x20;

* Gene burden data for Parkinson’s disease
* Updated classifications for clinical trial stop reasons
* Variant functional consequences, available to browse in the Gene2Phenotype and Orphanet widgets
* Other improvements and bug fixes

Check out the [22.11 release blog post](https://blog.opentargets.org/open-targets-platform-22-11-release/) for more information on the new features and datasets introduced in this release.

### Overall data metrics

* 62,678 targets
* 22,274 diseases and phenotypes
* 12,854 drugs and compounds
* 14,611,717 evidence strings
* 6,960,486 target-disease associations

Visit the [Open Targets Community 22.11 release thread](https://community.opentargets.org/t/22-11-platform-release-now-live/870) for more data metrics for this release, including a per datasource breakdown of evidence strings.



## 22.09

### Release date

29 September 2022

### Highlights

New data, in particular:

* Open Targets Genetics
* Genomics England PanelApp
* Gene burden
* Probes and drugs
* New data integrity file, in line with FAIR principles

Check out the[ 22.09 release blog post](https://blog.opentargets.org/open-targets-platform-22-09-release/) for more information on the new features and datasets introduced in this release.\


### Overall data metrics

* 61,888 targets
* 20,931 diseases and phenotypes
* 12,854 drugs and compounds
* 14,229,684 evidence strings
* 7,003,171 target-disease associations

Visit the [Open Targets Community 22.09 release thread](https://community.opentargets.org/t/22-09-platform-release-now-live/783) for more data metrics for this release, including a per datasource breakdown of evidence strings.

## 22.06

### Release date

24 June 2022

### Highlights

* New data: five additional gene burden analyses from Genebass
* New feature: new visualisation of subcellular locations of targets now available to users
*   New ontology term: “medical procedure”&#x20;



Check out the [22.06 release blog post](https://blog.opentargets.org/open-targets-platform-22-06-release/) for more information on the new features and datasets introduced in this release.&#x20;

### Overall data metrics

* 61,524 targets
* 23,074 diseases and phenotypes
* 12,854 drugs and compounds
* 14,455,104 evidence strings
* 7,247,865 target-disease associations

Visit the [Open Targets Community 22.06 release thread](https://community.opentargets.org/t/the-latest-release-22-06-is-now-live/675) for more data metrics for this release, including a per datasource breakdown of evidence strings.

## 22.04

### Release date

28 April 2022

### Highlights

* New datasource: gene burden analyses from Regeneron and the AstraZeneca
* Integration of structural variants from ClinVar
* Additional information from DailyMed drug label text-mining
* NLP classification of why clinical trials stopped
* New data: Gene2phenotype cardiac panel

Check out the[ 22.04 release blog post](https://blog.opentargets.org/open-targets-platform-22-04-release/) for more information on the new features and datasets introduced in this release.&#x20;

### Overall data metrics

* 61,524 targets
* 18,520 diseases and phenotypes
* 12,854 drugs and compounds
* 13,829,174 evidence strings
* 7,541,360 target-disease associations

Visit the [Open Targets Community 22.04 release thread](https://community.opentargets.org/t/open-targets-platform-22-04-is-out-now/555) for more data metrics for this release, including a per datasource breakdown of evidence strings.

## 22.02

### Release date

28 February 2022

### Highlights

* Gene2Phenotype terminology updated in line with the Gene Curation Coalition (GenCC)
* Data updates from a range of providers including Open Targets Genetics and ChEMBL

Check out the [22.02 release blog post](https://blog.opentargets.org/open-targets-platform-22-02-release/) for more information on the new features and datasets introduced in this release.&#x20;

### Overall data metrics

* 61,524 targets
* 18,468 diseases and phenotypes
* 12,594 drugs and compounds
* 10,880,832 evidence strings
* 7,980,448 target-disease associations

Visit the [Open Targets Community 22.02 release thread](https://community.opentargets.org/t/open-targets-platform-22-02-has-been-released/476) for more data metrics for this release, including a per datasource breakdown of evidence strings.

## 21.11

### Release date

29 November 2021

### Highlights

* New Cancer Biomarkers evidence data from the Cancer Genome Interpreter
* Updated genetic association evidence from Open Targets Genetics
* Embedded GraphQL API playground for each data table and query

Check out the [21.11 release blog post](https://blog.opentargets.org/open-targets-platform-21-11-release/) for more information on the new features and datasets introduced in this release.&#x20;

### Overall data metrics

* 60,636 targets
* 18,706 diseases and phenotypes
* 12,594 drugs and compounds
* 10,481,189 evidence strings
* 7,787,231 target-disease associations

Visit the[ Open Targets Community 21.11 release thread](https://community.opentargets.org/t/open-targets-platform-21-11-has-been-released/413) for more data metrics for this release, including a per datasource breakdown of evidence strings.

## 21.09

### Release date

30 September 2021

### Highlights

* Integration of new PROTAC tractability data from [Schneider et al. (2021)](https://doi.org/10.1038/s41573-021-00245-x)
* Integration of Genetic Constraint data from gnomAD and new Chemical Probes data from Probes & Drugs database
* Data updates from EFO, ChEMBL, and Mouse Genome Informatics
* Other improvements and bug fixes

Check out our [21.09 release blog post](https://blog.opentargets.org/open-targets-platform-21-09-release/) for more information on the new features and datasets introduced in this release.

### Overall data metrics

* 60,636 targets
* 18,663 diseases and phenotypes
* 12,594 drugs and compounds
* 11,071,233 evidence strings
* 7,927,820 target-disease associations

Visit the [Open Targets Community 21.09 release thread](https://community.opentargets.org/t/21-09-platform-release-now-live/364) for more data metrics for this release, including a per datasource breakdown of evidence strings.

## 21.06

### Release date

30 June 2021

### Highlights

* Updated Open Targets Genetics Portal evidence, which included the integration of FinnGen biobank data (R5) and new GWAS Catalog studies
* Integration of gene-disease data from Orphanet
* Improvements to the user interface (e.g. datatype chips on evidence page)
* Bug fixes (e.g. users can download Known Drugs table, association scores in datasets match values returned by API)

Check out our [21.06 release blog post](https://blog.opentargets.org/open-targets-platform-21-06-release/) for more information on the new features and datasets introduced in this release.

### Overall data metrics

* 60,606 targets
* 18,507 diseases and phenotypes
* 13,185 drugs and compounds
* 13,267,236 evidence strings
* 9,216,710 target-disease associations

Visit the [Open Targets Community](https://community.opentargets.org/t/21-06-platform-release-now-live/244) for more data metrics for this release, including a per datasource breakdown of evidence strings.

## Archive

For release notes for previous releases, check out the [Open Targets Community News & Announcement section](https://community.opentargets.org/c/news-and-announcements/5).
